EAACI Congress 2025
BackSAT15 - GSK – Is disease modification possible in severe asthma?
Saturday 14 Jun, 12:00 PM -
13:00 PM Glasgow, United Kingdom
Forth
Sponsored Sessions
Objectives
• To summarise clinical remission as an achievable treatment goal for patients with severe asthma and to outline the evidence for greater benefit with earlier biologic intervention, with a view on future management approaches
• To inform on the biology and consequences of mucus plugging in asthma and discuss how it drives pathological processes and disease progression
• To highlight airway remodelling as a key contributor to disease progression in severe asthma, and the opportunities for intervention
12:00
Welcome and general introduction
12:05
Clinical remission: achieving disease control in severe asthma
12:20
Mucus plugging and airway obstruction in severe asthma
12:35
Airway remodelling and its relevance to disease progression in severe asthma
12:50
Q&A and concluding remarks
